A phase 2, double-blind, multicenter, randomized, placebo-controlled, dose‑ranging study of the efficacy and safety of Astodrimer Gel for the treatment of bacterial vaginosis

• Arthur S. Waldbaum,

  Roles Investigation, Writing – review & editing

  Affiliation Downtown Women’s Health Care, Denver, CO, United States of America

  ⨯
• Jane R. Schwebke,

  Roles Writing – review & editing

  Affiliation Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, AL, United States of America

  ⨯
• Jeremy R. A. Paull ,

  Roles Conceptualization, Project administration, Resources, Supervision, Visualization, Writing – review & editing

  * E-mail: jeremy.paull@starpharma.com

  Affiliation Starpharma Pty Ltd, Melbourne, VIC, Australia

  http://orcid.org/0000-0002-9981-421X

  ⨯
• Clare F. Price,

  Roles Conceptualization, Project administration, Resources, Supervision, Writing – review & editing

  Affiliation Starpharma Pty Ltd, Melbourne, VIC, Australia

  ⨯
• Stephanie R. Edmondson,

  Roles Project administration, Writing – review & editing

  Affiliation Starpharma Pty Ltd, Melbourne, VIC, Australia

  ⨯
• Alex Castellarnau,

  Roles Visualization, Writing – original draft, Writing – review & editing

  Affiliation Starpharma Pty Ltd, Melbourne, VIC, Australia

  ⨯
• Philip McCloud,

  Roles Formal analysis, Writing – review & editing

  Affiliation McCloud Consulting Group, Sydney, NSW, Australia

  ⨯
• George R. Kinghorn

  Roles Conceptualization, Methodology, Writing – review & editing

  Affiliation Royal Hallamshire and Sheffield Teaching Hospitals, Sheffield, United Kingdom

  ⨯